Pay for Quality

KCE Reports 118 Pay for Quality 169
94. Robinson JC. Theory and practice in the design of physician payment incentives. Milbank
Quarterly. 2001;79(2):149-+.
95. Averill RF, Vertrees JC, McCullough EC, Hughes JS, Goldfield NI. Redesigning medicare
inpatient PPS to adjust payment for post-admission complications. Health Care Financing
Review. 2006;27(3):83-93.
96. Pronovost PJ, Goeschel CA, Wachter RM. The wisdom and justice of not paying for
"preventable complications". Jama-Journal of the American Medical Association.
97.
2008;299(18):2197-9.
Rosenthal MB. Nonpayment for performance? Medicare's new reimbursement rule. New
England Journal of Medicine. 2007;357(16):1573-5.
98. Cromwell J, Drozd EM, Smith K, Trisolini M. Financial gains and risks in pay-for-performance
bonus algorithms. Health Care Financing Review. 2007;29(1):5-14.
99. Nolan T, Berwick DM. All-or-none measurement raises the bar on performance. Jama-Journal
of the American Medical Association. 2006;295(10):1168-70.
100. Reeves D, Campbell SM, Adams J, Shekelle PG, Kontopantelis E, Roland MO. An evaluation of
different analytic approaches. Medical Care. 2007;45(6):489-96.
101. Caldis T. Composite health plan quality scales. Health Care Financing Review. 2007;28(3):95-
107.
102. Ferreira-Gonzalez I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, Bryant DM, et al.
Problems with use of composite end points in cardiovascular trials: systematic review of
randomised controlled trials. British Medical Journal. 2007;334(7597):786-8A.
103. Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Greater precision but with greater
uncertainty? Jama-Journal of the American Medical Association. 2003;289(19):2554-9.
104. Freemantle N, Calvert M. Composite end points may mislead - and regulators allow it to
happen. British Medical Journal. 2007;334(7597):756-7.
105. Montori VM, Permanyer-Miralda G, Ferreira-Gonzalez I, Busse JW, Pacheco-Huergo V, Bryant
D, et al. Validity of composite end points in clinical trials. British Medical Journal.
2005;330(7491):594-6.
106. O'Brien SM, Delong ER, Dokholyan RS, Edwards FH, Peterson ED. An example from coronary
artery bypass surgery. Circulation. 2007;116(25):2969-75.
107. Nahra TA, Reiter KL, Hirth RA, Shermer JE, Wheeler JRC. Cost-effectiveness of hospital payfor-performance
incentives. Medical Care Research and Review. 2006;63(1):49S-72S.
108. Eisenhardt KM. Agency theory:Anassessment and review. The Academy ofManagementReview.
1989;14(1):57-74.
109. Figueras J, Robinson R, Jakubowski E. Purchasing to improve health systems performance.
Open University Press; 2005.
110. Buetow S. What motivates health professionals? Opportunities to gain greater insight from
theory. J Health Serv.Res.Policy. 2007;12(3):183-5.
111. Marshall M, Harrison S. It's about more than money: financial incentives and internal
motivation. Qual.Saf Health Care. 2005;14(1):4-5.
112. Adams O, Hicks V. Pay and Non-pay Incentives, Performance and Motivation Prepared for
WHO's December 2000 Global Health Workforce Strategy Group, Geneva. Human
Resources for Health Development Journal (HRDJ). 2000;4(3):126-45.
113. Wazana A. Physicians and the pharmaceutical industry: is a gift. Journal of the American
Medical Association. 2000;283:373-80.
114. Berenson RA, Ginsburg PB, May JH. Hospital-physicians relations: cooperation, competition, or
separation? Health Aff.(Millwood.). 2007;26(1):w31-w43.
115. Berwick DM, DeParle NA, Eddy DM, Ellwood PM, Enthoven AC, Halvorson GC, et al. Paying
for performance: Medicare should lead. Health Aff.(Millwood.). 2003;22(6):8-10.
116. Safavi K. Aligning financial incentives. J.Healthc.Manag. 2006;51(3):146-51.
117. Gallagher TH, Levinson W. A prescription for protecting the doctor-patient relationship.
American Journal of Managed Care. 2004;10(2):61-8.
118. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Implications for pay for performance.
Jama-Journal of the American Medical Association. 2005;294(6):716-24.